[1] 张瑾, 吴玉梅, 孔为民, 等.763例Ⅲ期宫颈癌不同放疗方法的疗效分析[J].中华放射肿瘤学杂志, 2008, 17(5):364-367. DOI:10.3321/j.issn:1004-4221.2008.05.009.
Zhang J, Wu YM, Kong WM, et al.Treatment results of different radiotherapy for 763 patients with advanced cervical cancer[J].Chin J Radiat Oncol, 2008, 17(5):364-367.  doi: 10.3321/j.issn:1004-4221.2008.05.009
[2] 黄建敏, 潘莉萍, 李冬雪.PET和PET-CT在宫颈癌中的应用价值[J].国际放射医学核医学杂志, 2007, 31(2):112-114. DOI:10.3760/cma.j.issn.1673-4114.2007.02.016.
Huang JM, Pan LP, Li DX.The application of PET and PET-CT in cervical cancer[J].Int J Radiat Med Nucl Med, 2007, 31(2):112-114.  doi: 10.3760/cma.j.issn.1673-4114.2007.02.016
[3] Du XL, Tao J, Sheng XG, et al.Intensity-modulated radiation therapy for advanced cervical cancer:a comparison of dosimetric and clinical outcomes with conventional radiotherapy[J].Gynecol Oncol, 2012, 125(1):151-157. DOI:10.1016/j.ygyno.2011.12.432.
[4] Chen CC, Lin JC, Jan JS, et al.Definitive intensity-modulated radiation therapy with concurrent chemotherapy for patients with locally advanced cervical cancer[J].Gynecol Oncol, 2011, 122(1):9-13. DOI:10.1016/j.ygyno.2011.03.034.
[5] Zhang G, Fu C, Zhang Y, et al.Extended-field intensity-modulated radiotherapy and concurrent cisplatin-based chemotherapy for postoperative cervical cancer with common iliac or para-aortic lymph node metastases:a retrospective review in a single institution[J].Int J Gynecol Cancer, 2012, 22(7):1220-1225. DOI:10.1097/IGC.0b013e3182643b7c.
[6]

Marnitz S, Köhler C, Burova E, et al.Helical tomotherapy with simultaneous integrated boost after laparoscopic staging in patients with cervical cancer: analysis of feasibility and early toxicity[J/OL].Int J Radiat Oncol Biol Phys, 2012, 82(2): e137-e143[2016-09-13].http://www.sciencedirect.com/science/acticle/pii/S0360301610036382. DOI: 10.1016/j.ijrobp.2010.10.066.
[7] Vandecasteele K, De Neve W, De Gersem W, et al.Intensity-modulated arc therapy with simultaneous integrated boost in the treatment of primary irresectable cervical cancer.Treatment planning, quality control, and clinical implementation[J].Strahlenther Onkol, 2009, 185(12):799-807. DOI:10.1007/s00066-009-1986-8.
[8] Koh WY, Lim K, Tey J, et al.Outcome of 6 fractions of 5.3 Gray HDR brachytherapy in combination with external beam radiotherapy for treatment of cervical cancer[J].Gynecol Oncol, 2013, 131(1):93-98. DOI:10.1016/j.ygyno.2013.07.102.
[9] Boyle J, Craciunescu O, Steffey B, et al.Methods, safety, and early clinical outcomes of dose escalation using simultaneous integrated and sequential boosts in patients with locally advanced gynecologic malignancies[J].Gynecol Oncol, 2014, 135(2):239-243. DOI:10.1016/j.ygyno.2014.08.037.
[10] Marnitz S, Stromberger C, Kawagan-Kagan M, et al.Helical tomotherapy in cervical cancer patients:simultaneous integrated boost concept:technique and acute toxicity[J].Strahlenther Onkol, 2010, 186(10):572-579. DOI:10.1007/s00066-010-2121-6.
[11] Guerrero M, Li XA, Ma L, et al.Simultaneous integrated intensity-modulated radiotherapy boost for locally advanced gynecological cancer:radiobiological and dosimetric considerations[J].Int J Radiat Oncol Biol Phys, 2005, 62(3):933-939. DOI:10.1016/j.ijrobp.2004.11.040.
[12] Harris EE, Latifi K, Rusthoven C, et al.Assessment of organ motion in postoperative endometrial and cervical cancer patients treated with intensity-modulated radiation therapy[J].Int J Radiat Oncol Biol Phys, 2011, 81(4):E645-E650. DOI:10.1016/j.ijrobp.2011.01.054.
[13]

Macchia G, Cilla S, Deodato F, et al.Intensity-modulated extended-field chemoradiation plus simultaneous integrated boost in the pre-operative treatment of locally advanced cervical cancer: a dose-escalation study[J/OL].Br J Radiol, 2015, 88(1055): 20150385[2016-09-13].https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4743458. DOI: 10.1259/bjr.20150385.
[14] 朱卫国, 于长华, 李涛, 等.国产奈达铂用于宫颈癌同步放化疗的剂量递增试验[J].中华肿瘤杂志, 2011, 33(7):525-526. DOI:10.3760/cma.j.issn.0253-3766.2011.07.011.
Zhu WG, Yu CH, Li T, et al.Dose escalation of domestic nedaplatin used in concurrent chemoradiotherapy for cervical cancer[J].Chin J Oncol, 2011, 33(7):525-526.  doi: 10.3760/cma.j.issn.0253-3766.2011.07.011
[15] Gandhi AK, Sharma DN, Rath GK, et al.Early clinical outcomes and toxicity of intensity modulated versus conventional pelvic radiation therapy for locally advanced cervix carcinoma:a prospective randomized study[J].Int J Radiat Oncol Biol Phys, 2013, 87(3):542-548. DOI:10.1016/j.ijrobp.2013.06.2059.